期刊文献+

非瓣膜病性心房纤颤患者华法林抗凝治疗的安全性研究

下载PDF
导出
出处 《实用临床医学(江西)》 CAS 2005年第9期151-152,156,共3页 Practical Clinical Medicine
  • 相关文献

参考文献13

  • 1抗心律失常药物治疗专题组.抗心律失常药物治疗建议[J].中华心血管病杂志,2001,29(6):323-336. 被引量:788
  • 2孙艺红,胡大一.华法林对中国人心房颤动患者抗栓的安全性和有效性研究[J].中华内科杂志,2004,43(4):258-260. 被引量:170
  • 3Kannel WB,Abbott RD,Savage DD,et al.Epidemiologic features of chronic atrial fibrillation:the Framingham Study[J].N Engl J Med,1982,306(7):1 018~1 022.
  • 4Wolf PA,Abbott RD,Kannel WB.A major contributor to stroke in the elderly[J].Arch Intern MED,1987,147(2):1 561~1 564.
  • 5Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:The Framingham Study[J].Stroke,1991,22(4):983~988.
  • 6蒋文平,朱俊,戚文航,吴宁.如何对待心房颤动[J].中华心血管病杂志,2003,31(7):483-486. 被引量:125
  • 7Aronow WS,Ahn C,Kronzon L,et al.Risk factors for new thromboemb-olic stroke in patients≥62 years of age with chronic atrial fibrillation[J].Am J Cardial,1998,82(1):119.
  • 8Hart RC,Pearce LA,Mcbride R,et al,Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation:analysis of 2012 participants in the SPAFⅠ~Ⅱ clinical trial[J].Stroke,1991,30(6):1 223.
  • 9Hart RG,Halperin JL.Atrial Fibrillation and stroke and stroke concept and controversies[J].Stroke,2001,32(9):803.
  • 10Mugge A.Anticoagulation in patients with atrial fibrillation[J].Herz,1996,21(3):28~36.

二级参考文献16

  • 1方圻,王思让.心律失常的临床对策[J].中华心血管病杂志,1993,21(1):5-14. 被引量:39
  • 2Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the
  • 3Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 2001,119(1 Suppl):8S-21S.
  • 4Levine MN, Raskob G, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment. Chest, 2001,119(1 Suppl):108S-121S.
  • 5The stroke prevention in atrial fibrillation investigation. Bleeding during antithrombotic thearapy in patients with atrial fibrillation. Arch Intern Med, 1996, 156:409-416.
  • 6Fihn SD, Callahan CM, Martin DC, et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med, 1996,124:970-979.
  • 7Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med,1994,120:897-902.
  • 8Stroke prevention in atrial fibrillation investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation Ⅲ randomized clinic trial. Lan
  • 9Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of reccurrent venous thromboembolism. N Engl J Med, 2003,348:1425-1434.
  • 10朱俊,宋有城,卢才义,方卫华.异搏定、心律平和三磷酸腺苷终止室上性心动过速的对比[J].中国循环杂志,1989,4(4):340-341. 被引量:5

共引文献1055

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部